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Abstract 
Within just nine months of its official identification by the World Health Organization, coronavirus disease 2019 
(COVID-19) has caused 34 million confirmed infections and about 1 million deaths worldwide. The collateral 
damage and spill over effects to all sectors has caused severe social disruption and an economic crisis that the world 
was unprepared for. Despite the relentless global effort, the pandemic remains a serious threat to lives and livelihood. 
As a result, all countries are faced with the daunting task of balancing outbreak prevention strategies against efforts 
to save their economies. Nevertheless, almost every country now has months of local evidences about the pandemic 
that will support contextualized and measured actions. 
The number of confirmed cases and deaths attributable to COVID-19 in Ethiopia has steadily increased since the 
first reported case on 13 March 2020. Although the country has so far avoided the feared catastrophe, the true burden 
of the problem may be far beyond what has been reported due to limited testing capacity. With the current trends of 
widespread community transmission, COVID-19 remains a serious public health threat in the country. In addition, 
multiple human-related and environmental factors, combined with relaxed COVID-19 mitigation strategies, have 
put the country at a high epidemic risk. Thus, proactive and balanced measures based on local evidence should be 
taken to prevent the country from slipping into a dire public health crisis. [Ethiop. J. Health Dev. 2020; 34(4):301-
306] 
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Introduction 
Coronavirus disease 2019 (COVID-19) will probably 
remain a phenomenal disease in the history of 
medicine for many reasons. From the initial report of 
a ‘mysterious human respiratory illness’ in Wuhan, 
China in late December 2019 (1), it took less than 
three months to spread to over 200 countries (2). 
Furthermore, in just nine months since its official 
recognition by the World Health Organization 
(WHO), COVID-19 has caused 34 million confirmed 
infections and about 1 million deaths worldwide (3). 
However, the threat posed by the pandemic is much 
more than numbers can convey. The collateral 
damage and spillover effects to all sectors are still 
unfolding and will probably take years, if not 
decades, to overcome (4).  
 
Nevertheless, the remarkable ‘achievement’ in the fight 
against the pandemic will undoubtedly have a lasting 
effect in the practice of medicine. Never before in the 
history of medicine has the world developed a vaccine 
in clinical trials in less than a year since the discovery 
of a new disease (5). There are currently a staggering 
169 COVID-19 vaccines under development 
worldwide, 26 of which are at the clinical trial stage (at 
least nine of them are in phase III clinical trials) (6). The 
world might have also learned the value of hand 
hygiene in disease prevention more than ever before 
(7). These achievements and lessons will surely change 
our approaches in the fight against existing diseases for 
the better.  
 
Despite all these positive developments, the risk posed 
by the pandemic remains high. The numbers of new 
infections and deaths are surging all over the world. 
However, every country is faced with the dilemma of 
saving its economy and safeguarding its nation from the 
pandemic (8). Because the global distribution of the 
pandemic does not follow similar patterns due to the 
peculiar demographic and socio-economic nature of 
each country, specific interventions should be based on 
local data (9). Moreover, as mitigating actions are likely 
to have far-reaching consequences, strategies should be 
tailored to the local context, based on the risk posed by 
the outbreak and the ‘cost’ of possible actions. In this 
review, we will present how COVID-19 unfolded in 
Ethiopia in the first 180 days and the lessons learned so 
far. We will also extrapolate the risks in the near future 
and detail possible strategies to contain the outbreak. 
  
How did COVID-19 unfold in Ethiopia? 
Important milestones (10) 
⁻  13 March 2020 – First confirmed case in Ethiopia 
⁻  19 March 2020 – First case with severe disease  
⁻  29 March 2020 – The first case outside Addis Ababa (three cases reported in Adama) 
⁻  05 April 2020 – First COVID-19-related death in Ethiopia 
⁻  79 days – the time it took to reach the first 1,000 cases  
⁻  Nine days – the time it took to reach the next 1,000 cases after the first 1,000. 
 
Outbreak summary after day 180 (as at 09 September 2020) (10) 
⁻  Total laboratory tests – 1,093,830 
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⁻  Total number of cases – 61,700 
o Overall test positivity rate – 5.64%  
⁻  Recovered cases – 23,054 
⁻  Total COVID-19-related deaths – 966 
o Death rate among known outcomes – 4.02% 
o Death rate among all cases – 1.57% 
⁻  Active cases – 37,678 
⁻  Cases with severe disease – 319 
o Rate of severe disease among active cases – 0.85% 
⁻  Older people (≥60 years) accounted for only 7% of the cases, but for 53% of the deaths (11) 
⁻  Addis Ababa is the major hotspot – about 40% of laboratory tests, 58% of the cases and 78% of the 
deaths were reported in the city (see Figure 1) 
 
Figure 1: Laboratory tests, total cases, and deaths by regional states in Ethiopia in the first 180 days of the 
COVID-19 outbreak 
Data sources: Daily press release  by FMoH (10), EPHI weekly bulletin (12), and daily reports by regional health 
bureaus 
 
Pattern of testing and test positivity rate 
The daily testing capacity in Ethiopia evolved from less 
than 100 tests daily until the first week of April, to the 
highest of 25,158 tests on 06 September 2020. The test 
positivity rate declined from an average of 5% in the first 
few weeks to less than 1% during mid-April to mid-May 
2020. However, the rate gradually increased to reach the 
highest of 10.46% on 24 July 2020. Since then, it has 
become stable at an average of 7% (see Figure 2).  
 
Figure 2: Trends of test positivity and disease outcome in COVID-19 cases in Ethiopia in the first 180 days of 
the outbreak 
Graph constructed from daily reports by FMoH (10) 
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Pattern of disease severity and case fatality 
Death rates among known outcomes and rates of severe 
disease among actives cases were high during the early 
weeks of the outbreak because only a relatively few 
cases were tested and diagnosed. These rates gradually 
declined from mid-April to mid-May (see Figure 1). 
However, the number of deaths remained more than the 
number of cases with severe disease. This happened 
because most reported COVID-19-related deaths in 
Ethiopia happened outside of health facilities and were 
incidentally detected during postmortem evaluation. For 
instance, of the 505 deaths reported as COVID-19-
related in Addis Ababa up to the end of August 2020, 
the virus was recovered from dead bodies in 321 
(63.6%) of the cases (10)).  
 
Lessons learned 
1. Mitigation strategies when implemented properly 
are effective and help prevent catastrophe. During 
the first few weeks of the pandemic, the test 
positivity rates, case fatality rates among known 
outcomes, and ICU admission rates among active 
cases were high. This was most likely because of 
the fact that testing was done only in symptomatic 
cases and contacts of confirmed cases. Most of 
these rates declined from mid-April to mid-May. 
The test positivity rate dropped to below 0.2% 
between 22 April and 03 May 2020. The number of 
recovered cases overtook active cases between 01 
and 08 May 2020. In addition, ICU admissions 
remained at zero between 21 April and 06 May (see 
Figure 2). These achievements matched the 
mitigation strategies taken nationally in March and 
April (11). These included: 
⁻  Huge media coverage and proactive public 
awareness creation activities by all 
stakeholders  
⁻  School closures from 16 March 2020 
⁻  Mandatory quarantine for international arrivals 
from 23 March 2020 
⁻  Most regional states banned public transport as 
of 30 March 2020. This remained in effect for 
at least two weeks  
⁻  State of emergency declared on 08 April 2020 
⁻  Semi-lockdown actions in March and April 
⁻  Launch of national hygiene and preventive 
measures movement, with hand washing 
facilities in most public places 
⁻  The banning of public gatherings, including at 
places of religious worship.  
 
However, most of these initiatives became weaker 
by May due to public fatigue, and the pattern of the 
outbreak started to escalate thereafter. This shows 
that epidemic control strategies during an ongoing 
outbreak should not be one-time campaigns. A 
sustained and innovative approach is required to 
motivate the public at large to remain vigilant.  
 
2. The more laboratory tests are conducted, the more 
cases are detected. Evidence is emerging that many 
people affected by COVID-19 remain 
asymptomatic but can still transmit the infection, 
making control strategies challenging (13). As a 
result, the disease may silently spread in the 
community unless proactively investigated. 
Ethiopia enhanced testing strategies with the 
Community-Based Actions and Testing (ComBAT) 
campaign in August. As a result, 54.5% of the total 
tests (584,820 of the total 1,093,830 tests) were 
performed in 30 days only. Consequently, 38,112 of 
the total 61,700 cases as of 09 September (61.8%) 
were detected during the same time. The number of 
severe diseases and COVID-19-related deaths also 
increased during this period.  
3. There is widespread community transmission. The 
proportion of positive cases among laboratory 
tested   is a critical measure for public health 
intervention of the outbreak. A higher test positivity 
rate suggests higher community transmission of the 
disease or a low testing rate (14). WHO in May 
recommended that for any country to re-open from 
lockdown, the test positivity rate should remain less 
than 5% for at least two weeks. The 5% positivity 
rate is often used as a good margin because any rate 
above this translates to large-scale community 
transmission (15). In Ethiopia, the national average 
for test positivity remained above 5% for over three 
months while it has been over 10% in Addis Ababa. 
Translating the high positivity rate as high 
community transmission may be inaccurate. 
However, the fact that this rate remained above 5% 
during enhanced testing in August suggests that the 
reported cases represent only a minority of the 
actual cases in the country. Furthermore, a sero-
prevalence study conducted by the Ethiopian Public 
Health Institute across the country found that 4.5% 
of the population have antibodies against the virus 
(11). 
4. The reported COVID-19-related death rate is 
highly inaccurate. Knowing the true morbidity and 
mortality from COVID-19 remains a challenge 
globally. As asymptomatic cases are less likely to 
be tested, the reported case fatality rate, which 
considers confirmed cases only, is likely to be 
exaggerated. On the other hand, reported COVID-
19 deaths may be underestimated, as affected 
people may die at home without accessing any 
healthcare (16). Thus, it is important that COVID-
19-related deaths are recorded based on a clear and 
unambiguous case definition.  
 
According to WHO’s guidelines, a COVID-19-
related death is defined as any death directly 
resulting from clinical conditions compatible with a 
probable or confirmed COVID-19 case. This 
definition excludes deaths influenced by COVID-
19, but caused by another disease, or deaths that 
happen due to unrelated conditions but the virus 
was incidentally detected (17). However, the 
Ethiopian national report indiscriminately includes 
all deaths as COVID-19-related just because the 
virus is detected in the person before death or from 
the dead body, no matter what the immediate cause 
of death was (18).   Attributing all such deaths to 
the outbreak distorts the true case fatality rate of the 
disease. Moreover, as testing is random and 
COVID-19 in Ethiopia in the first 180 days      304 
 
Ethiop. J. Health Dev.2020;34(4) 
unpredictable, mortality in the Ethiopian context, 




Projecting the trend of the outbreak may not be easy 
given that it depends on multiple factors (19). However, 
the exponential nature of the disease spread, and the fact 
that most of the national mitigation strategies are now 
completely relaxed, create much uncertainty. On top of 
that, there is widespread public fatigue, a reluctance to 
implement preventive measures, and conspiracy 
theories that distract and misinform the public (20). 
Hence, it is possible to predict that Ethiopia is still far 
from the peak of the outbreak.  
 
There are also environmental factors that pose a great 
risk of enhancing disease transmission. September to 
November is regarded as   flu season – a period of 
heightened respiratory illness in Ethiopia (21, 22). This 
period is known for high rates of hospitalization due to 
bronchial asthma and lower respiratory tract infections, 
particularly in children (23). The well-known ‘Spanish 
flu’ (The 1918 Influenza Pandemic), historically known 
as Yehedar Besheta, is reported to have caused serious 
causalities in these months (24).  
    
Besides, after the end of rainy season in September in 
Ethiopia, the dry season ensues, accompanied by 
dropping relative humidity and an increment in dust and 
pollen levels. These environmental factors are known 
for allergic sensitization and worsening of chronic 
respiratory disease (25), and hence represent a risk for 
severe COVID-19. 
 
Although COVID-19 itself does not appear to be 
seasonal, not taking strong preventive measures during 
this period (September-December) may overwhelm  
COVID-19 critical care units, as the course and 
prognosis of COVID-19 may be worse during 
coinfection with seasonal flu, as has been witnessed in 
patients with comorbid respiratory illness (26). On the 
other hand, putting strong COVID-19 preventive 
strategies in place may help to reduce the incidence of 
seasonal flu during these months in Ethiopia. 
 
Recommended actions 
Because of the reasons listed above and multiple other 
global uncertainties, COVID-19 poses a greater risk in 
Ethiopia in the coming few months. The problem is 
compounded by the fact that the healthcare system is 
already strained and struggling to contain the pandemic. 
Hence, the risk posed by this pandemic is likely to get 
worse if not properly handled. Short of ‘a magic bullet’ 
at hand, preventive strategies should be tailored to the 
context. However, these measures come at a cost and 
thus should balance between effective containment of 
the outbreak and minimizing collateral damage. The 
following issues deserve special attention, among 
others, for effective handling of the outbreak: 
 
1. Major focus should be on reducing mortality – 
Reports from COVID-19 treatment and isolation 
centers in Ethiopia show that the vast majority of 
people who test positive for the virus either have no 
symptoms or only mild ones (11, 12). As the 
number of COVID-19 cases increases, this will 
overwhelm health facilities beyond their capacities. 
The recent enhanced testing strategies of the 
ComBAT campaign in August 2020 showed that 
there is already widespread community 
transmission. Although tracing, testing, and 
isolation of all contacts are essential to cut disease 
transmission, limited laboratory capacity and long 
delays for test results, as often observed in routine 
practice, raise questions about its benefit in such 
settings with widespread community transmission. 
Due to these limitations, the country should focus 
on reducing mortality by targeting and prioritizing 
testing for the most vulnerable groups. Besides, 
COVID-19 isolation and treatment centers should 
be dedicated for the high risk and those with severe 
disease. Moreover, continuous public awareness 
creation and education on prevention strategies and 
monitoring of their implementation should be 
strengthened.  
2. School opening – More than 26 million school 
children have not attended school since March 2020 
in Ethiopia due to school closures (27). Although 
this has been a challenging time for children, 
families and the country, evidence shows that the 
early closure of schools has prevented widespread 
outbreaks in several countries (28, 29). Other 
countries have also reported a surge in COVID-19 
cases after reopening schools, often leading to their 
closure shortly thereafter  (30, 31). Hence, although 
it is essential to return children to school and keep 
them on the educational track, the timing of school 
reopening should be guided by the best interests of 
the child and overall public health considerations, 
based on an assessment of local context. In 
Ethiopia, it is important to delay school opening 
until the pandemic is on its downward curve. 
Besides, as the pandemic will remain with us for a 
long time, it is important to   support and ensure 
schools to establish all the preventive measures and 
strategies for reopening. Most importantly, the 
country should design step-by-step opening of 
schools, as recommended by WHO and UNICEF 
(32). Such approaches are important to lessen the 
probability of a new outbreak and boost the 
confidence of parents, students, and teachers in 
terms of school safety. Otherwise, opening schools 
without establishing proper conditions may lead to 
new outbreaks that may in turn erode the confidence 
of families and ultimately lead to major dropouts 
from schools.  
3. Public transport and social gatherings – The cost 
for public transport had doubled when the 
government reduced the loading capacity by half to 
ensure physical distancing. However, this has been 
very challenging and unaffordable for the large 
majority of people that use public transport on daily 
basis. Therefore, other measures, such as hand 
hygiene and the use of masks, should be intensified 
in public transport. Moreover, public gatherings, 
where it is difficult to ensure the implementation of 
prevention strategies, need to be restricted.  
4. Research, data management, and exit strategy – It 
is essential to strengthen the quality of national data 
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collection, handling and management procedures 
regarding COVID-19 to produce evidence that will 
help design contextualized prevention and 
treatment strategies and policies. As the pandemic 
will remain with us for the foreseeable future, 
getting back to normality may take time. Some form 
of lockdown will remain in place and the country 
may also go back to some forms of restrictions if 
cases surge after lockdown has lifted. However, 
lockdowns pose considerable economic costs that 
threaten lives, put livelihoods at risk and exacerbate 
poverty. The country should thus plan for short-
term and long-term exit strategies that preserve 
lives while protecting livelihoods. Furthermore, 
Ethiopia should actively work and also collaborate 
on COVID-19 prevention and treatment research, 
including ongoing vaccine development and its 
access and distribution in the country.  
 
Conclusions 
The number of confirmed cases and deaths attributable 
to COVID-19 in Ethiopia has been steadily increasing 
since the first reported case on 13 March 2020. 
Nevertheless, the country has so far avoided the feared 
crisis from the outbreak. However, the true burden of the 
problem may be far beyond what has been reported due 
to limited testing capacity. With the current trend of 
larger outbreaks of community transmission, it seems 
that the true peak of the outbreak is yet to arrive. 
Besides, multiple human-related and environmental 
factors, on top of the relaxed mitigation strategies, put 
the country at a high epidemic risk. Thus, proactive and 
balanced measures based on local evidence should be 
taken in the country.  
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